CBS News Christina Ruffini takes a look at the controversial battle between supporters and opponents of Flibanserin or “Female Viagra“, which was recently rejected by an FDA panel. (Source: Health News: CBSNews.com)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
CBS News Christina Ruffini takes a look at the controversial battle between supporters and opponents of Flibanserin or “Female Viagra“, which was recently rejected by an FDA panel. (Source: Health News: CBSNews.com)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Title: ‘Female Viagra‘ Is Rejected by FDA PanelCategory: Health NewsCreated: 6/21/2010 10:59:00 AMLast Editorial Review: 6/21/2010 10:59:18 AM (Source: MedicineNet Menopause General)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
A pink pill designed to boost sex drive in women – the latest attempt by the drug industry to find a female equivalent to Viagra – fell short in two studies, federal health regulators said Wednesday.
The Food and Dr ug Administration is considering… (Source: OrlandoSentinel: Medical Research)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
On Friday, an FDA advisory panel voted 11-0 against recommending FDA approval of a proposed treatment for hypoactive sexual-desire disorder, which decreases women’s sex drive, the Wall Street Journal reports. The R eproductive Health Drugs Advisory Committee reviewed an application seeking FDA approval of the drug flibanserin, also known as the “pink pill” or “female Viagra.” Although the agency is not required to follow the panel’s recommendation, (more…)
WASHINGTON (Reuters) – A pink pill designed to offer women a counterpart to Viagra failed to boost female sex drive in two studies, U.S. drug reviewers said in documents released on Wednesday. (Source: Reuters: Health)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receiv e $5 free advertising.
A pink pill designed to boost sex drive in women — the latest attempt by the drug industry to find a female equivalent to Viagra — fell short in two studies, federa l health regulators said Wednesday. (Source: WDSU.com – Health)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
WASHINGTON — A pink pill designed to boost sex drive in women — the latest attempt by the drug industry to find a female equivalent to Viagra — fell short in two studies, federal health regulators said Wednesday.
The Food and Drug… (Source: OrlandoSentinel: Medical Research)
MedWorm Message: Register for MedMatcha, MedWorm’s m edical advertising network, and receive $5 free advertising.
WASHINGTON (AP) — A pink pi ll designed to boost sex drive in women — the latest attempt by the drug industry to find a female equivalent to Viagra — fell short in two studies, federal health regulators said Wednesday.
The Food and… (Source: OrlandoSentinel: Medical Research)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Abstract: The New View Campaign is a grassroots initiative begun in 1999 to challenge the over-medicalization of sex in the wake of publicity following the release of Viagra. This paper describes the history of the campaign and its activities, which started with analysing the construction of female sexual dysfunction, and moved on to develop a critical understanding of sexuality as a market for the pharmaceutical industry to exploit. The campaign (more…)